MovDisordV3, PascalFrancis, Curation, bibRecord, 001000

Smokeless tobacco use and the risk of Parkinson's disease mortality

Identifieur interne : 001000 ( PascalFrancis/Curation ); précédent : 000F99; suivant : 001001

Smokeless tobacco use and the risk of Parkinson's disease mortality

Auteurs : Eilis J. O'Reilly [États-Unis] ; Marji L. Mccullough [États-Unis] ; Ann Chao [États-Unis] ; S. Jane Henley [États-Unis] ; Eugenia E. Calle [États-Unis] ; Michael J. Thun [États-Unis] ; A. Ascherio [États-Unis]

Source :

Movement disorders [ 0885-3185 ] ; 2005.

RBID : Pascal:06-0002755

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Tabagisme, Parkinson maladie, Facteur risque, Mortalité, Tabac.
Wicri :
- topic : Tabagisme, Mortalité, Tabac.

English descriptors

KwdEn :
- Mortality, Nervous system diseases, Parkinson disease, Risk factor, Tobacco, Tobacco smoking.

Abstract

We examined the association between smokeless tobacco use and Parkinson's disease (PD) mortality as assessed by death certificate in a prospective cohort of 95,981 neversmoking men. In this cohort, smokeless tobacco use is inversely associated with PD mortality, with an age-adjusted risk of 0.22 (0.07-0.67) among current users compared to never users.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 20`
A06				`@2 10`
A08	`01`	`1`	`ENG`	`@1 Smokeless tobacco use and the risk of Parkinson's disease mortality`
A11	`01`	`1`		`@1 O'REILLY (Eilis J.)`
A11	`02`	`1`		`@1 MCCULLOUGH (Marji L.)`
A11	`03`	`1`		`@1 CHAO (Ann)`
A11	`04`	`1`		`@1 HENLEY (S. Jane)`
A11	`05`	`1`		`@1 CALLE (Eugenia E.)`
A11	`06`	`1`		`@1 THUN (Michael J.)`
A11	`07`	`1`		`@1 ASCHERIO (A.)`
A14	`01`			`@1 Department of Nutrition, Harvard School of Public Health @2 Boston, Massachusetts @3 USA @Z 1 aut. @Z 7 aut.`
A14	`02`			`@1 Epidemiology and Surveillance Research, American Cancer Society @2 Atlanta, Georgia @3 USA @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut. @Z 6 aut.`
A14	`03`			`@1 Department of Epidemiology, Harvard School of Public Health, and The Charming Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital @2 Boston, Massachusetts @3 USA @Z 7 aut.`
A20				`@1 1383-1384`
A21				`@1 2005`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000135138750230`
A44				`@0 0000 @1 © 2006 INIST-CNRS. All rights reserved.`
A45				`@0 7 ref.`
A47	`01`	`1`		`@0 06-0002755`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	`@0 We examined the association between smokeless tobacco use and Parkinson's disease (PD) mortality as assessed by death certificate in a prospective cohort of 95,981 neversmoking men. In this cohort, smokeless tobacco use is inversely associated with PD mortality, with an age-adjusted risk of 0.22 (0.07-0.67) among current users compared to never users.`
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C02	`03`	`X`		`@0 002B17A03`
C03	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 01`
C03	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 01`
C03	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 01`
C03	`02`	`X`	`FRE`	`@0 Tabagisme @5 02`
C03	`02`	`X`	`ENG`	`@0 Tobacco smoking @5 02`
C03	`02`	`X`	`SPA`	`@0 Tabaquismo @5 02`
C03	`03`	`X`	`FRE`	`@0 Parkinson maladie @5 03`
C03	`03`	`X`	`ENG`	`@0 Parkinson disease @5 03`
C03	`03`	`X`	`SPA`	`@0 Parkinson enfermedad @5 03`
C03	`04`	`X`	`FRE`	`@0 Facteur risque @5 09`
C03	`04`	`X`	`ENG`	`@0 Risk factor @5 09`
C03	`04`	`X`	`SPA`	`@0 Factor riesgo @5 09`
C03	`05`	`X`	`FRE`	`@0 Mortalité @5 10`
C03	`05`	`X`	`ENG`	`@0 Mortality @5 10`
C03	`05`	`X`	`SPA`	`@0 Mortalidad @5 10`
C03	`06`	`X`	`FRE`	`@0 Tabac @2 FX @5 11`
C03	`06`	`X`	`ENG`	`@0 Tobacco @2 FX @5 11`
C03	`06`	`X`	`SPA`	`@0 Tabaco @2 FX @5 11`
C07	`01`	`X`	`FRE`	`@0 Encéphale pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
N21				`@1 002`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001D21

Links to Exploration step

Pascal:06-0002755

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Smokeless tobacco use and the risk of Parkinson's disease mortality</title>
<author><name sortKey="O Reilly, Eilis J" sort="O Reilly, Eilis J" uniqKey="O Reilly E" first="Eilis J." last="O'Reilly">Eilis J. O'Reilly</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Nutrition, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Mccullough, Marji L" sort="Mccullough, Marji L" uniqKey="Mccullough M" first="Marji L." last="Mccullough">Marji L. Mccullough</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology and Surveillance Research, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Chao, Ann" sort="Chao, Ann" uniqKey="Chao A" first="Ann" last="Chao">Ann Chao</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology and Surveillance Research, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Henley, S Jane" sort="Henley, S Jane" uniqKey="Henley S" first="S. Jane" last="Henley">S. Jane Henley</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology and Surveillance Research, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Calle, Eugenia E" sort="Calle, Eugenia E" uniqKey="Calle E" first="Eugenia E." last="Calle">Eugenia E. Calle</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology and Surveillance Research, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Thun, Michael J" sort="Thun, Michael J" uniqKey="Thun M" first="Michael J." last="Thun">Michael J. Thun</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology and Surveillance Research, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Ascherio, A" sort="Ascherio, A" uniqKey="Ascherio A" first="A." last="Ascherio">A. Ascherio</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Nutrition, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Epidemiology, Harvard School of Public Health, and The Charming Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0002755</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 06-0002755 INIST</idno>
<idno type="RBID">Pascal:06-0002755</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001D21</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001000</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Smokeless tobacco use and the risk of Parkinson's disease mortality</title>
<author><name sortKey="O Reilly, Eilis J" sort="O Reilly, Eilis J" uniqKey="O Reilly E" first="Eilis J." last="O'Reilly">Eilis J. O'Reilly</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Nutrition, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Mccullough, Marji L" sort="Mccullough, Marji L" uniqKey="Mccullough M" first="Marji L." last="Mccullough">Marji L. Mccullough</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology and Surveillance Research, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Chao, Ann" sort="Chao, Ann" uniqKey="Chao A" first="Ann" last="Chao">Ann Chao</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology and Surveillance Research, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Henley, S Jane" sort="Henley, S Jane" uniqKey="Henley S" first="S. Jane" last="Henley">S. Jane Henley</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology and Surveillance Research, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Calle, Eugenia E" sort="Calle, Eugenia E" uniqKey="Calle E" first="Eugenia E." last="Calle">Eugenia E. Calle</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology and Surveillance Research, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Thun, Michael J" sort="Thun, Michael J" uniqKey="Thun M" first="Michael J." last="Thun">Michael J. Thun</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Epidemiology and Surveillance Research, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Ascherio, A" sort="Ascherio, A" uniqKey="Ascherio A" first="A." last="Ascherio">A. Ascherio</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Nutrition, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Epidemiology, Harvard School of Public Health, and The Charming Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Mortality</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Risk factor</term>
<term>Tobacco</term>
<term>Tobacco smoking</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Tabagisme</term>
<term>Parkinson maladie</term>
<term>Facteur risque</term>
<term>Mortalité</term>
<term>Tabac</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Tabagisme</term>
<term>Mortalité</term>
<term>Tabac</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We examined the association between smokeless tobacco use and Parkinson's disease (PD) mortality as assessed by death certificate in a prospective cohort of 95,981 neversmoking men. In this cohort, smokeless tobacco use is inversely associated with PD mortality, with an age-adjusted risk of 0.22 (0.07-0.67) among current users compared to never users.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>20</s2>
</fA05>
<fA06><s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Smokeless tobacco use and the risk of Parkinson's disease mortality</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>O'REILLY (Eilis J.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>MCCULLOUGH (Marji L.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>CHAO (Ann)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>HENLEY (S. Jane)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>CALLE (Eugenia E.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>THUN (Michael J.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>ASCHERIO (A.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Nutrition, Harvard School of Public Health</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Epidemiology and Surveillance Research, American Cancer Society</s1>
<s2>Atlanta, Georgia</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Epidemiology, Harvard School of Public Health, and The Charming Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>1383-1384</s1>
</fA20>
<fA21><s1>2005</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000135138750230</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>7 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0002755</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We examined the association between smokeless tobacco use and Parkinson's disease (PD) mortality as assessed by death certificate in a prospective cohort of 95,981 neversmoking men. In this cohort, smokeless tobacco use is inversely associated with PD mortality, with an age-adjusted risk of 0.22 (0.07-0.67) among current users compared to never users.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B17A03</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Tabagisme</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Tobacco smoking</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Tabaquismo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Facteur risque</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Risk factor</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Factor riesgo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Mortalité</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Mortality</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Mortalidad</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Tabac</s0>
<s2>FX</s2>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Tobacco</s0>
<s2>FX</s2>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Tabaco</s0>
<s2>FX</s2>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>002</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001000 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001000 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:06-0002755
   |texte=   Smokeless tobacco use and the risk of Parkinson's disease mortality
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Smokeless tobacco use and the risk of Parkinson's disease mortality

Smokeless tobacco use and the risk of Parkinson's disease mortality

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri